| Financial Year |
March 31 2023 |
| Monetary Funds |
142,805,996.68 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
12,454,677.14 |
| Accounts Receivable |
55,542,185.09 |
| Advances to Suppliers |
36,858,327.30 |
| Other Receivables |
10,330,338.10 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
11,725,201.80 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
494,091.13 |
| Total Current Assets |
279,266,108.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
476,982,362.92 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
-- |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
862,685.05 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
480,732,494.52 |
| Total Assets |
759,998,602.60 |
| Short-Term Loans |
30,025,055.52 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
28,389,003.58 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
45,528,854.14 |
| Taxes Payable |
6,530,602.88 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
38,521,719.39 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
14,268,325.33 |
| Other Current Liabilities |
11,243,174.95 |
| Sub-Total of Current Liabilities |
209,661,604.10 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
100,000.00 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,596,259.38 |
| Total Liabilities |
215,257,863.48 |
| Paid-In Capital(Or Share Stock) |
1,012,083,455.00 |
| Capital Surplus |
1,960,094,472.92 |
| Surplus Reserve |
292,590,381.39 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,679,298,501.72 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
544,740,739.12 |
| Owner's Equity（Stockholder's Equity） |
544,740,739.12 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
759,998,602.60 |
